Therefore, we tried to investigate whether RPL23 expression, which is one of our prognostic markers in this study, is also associated with the prognosis of patients with ccRCC as well as HGSC and identified a significant association between RPL23 expression and the prognosis of patients with ccRCC (Figure S5). This evidence concerns the gene RPL23 and nonpapillary renal cell carcinoma.